Abstract
Research conducted during the past several years has led to an increased understanding of the roles played by the viral protein Gag and specific cellular factors in HIV assembly/budding. The identification of compounds that interfere with this process validates this late step in virus replication as a target for HIV therapeutic discovery. In this review, current understanding of HIV-1 assembly/budding is described and several developmental stage drugs that target this process are reviewed.
| Original language | English |
|---|---|
| Pages (from-to) | 148-154 |
| Number of pages | 7 |
| Journal | Current Opinion in Investigational Drugs |
| Volume | 6 |
| Issue number | 2 |
| State | Published - 2005 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Assembly
- Budding
- Drug
- HIV-1
- Target
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
Fingerprint
Dive into the research topics of 'HIV-1 assembly and budding as targets for drug discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver